AeRang Kim, MD, PhD Oncologist



AeRang Kim, MD, PhD, is a member of the solid tumor faculty at Children’s National Health System and an Assistant Professor of Pediatrics. Dr. Kim's specializes in sarcomas and developmental therapeutics. Her research focuses on development of novel therapeutics for pediatric cancer including pre-clinical testing of novel agents, pharmacokinetic analysis, developing innovative methods for toxicity monitoring, and clinical trial design. She serves as the principal investigator of multiple early phase trials in pediatric oncology, sarcomas, and NF1 associated tumors.

Education & Training

Education & Training

  • PhD, 2009
    Johns Hopkins School of Public Health
  • Fellowship Program, Pediatric Hematology/Oncology, 2008
    Johns Hopkins Hospital
  • Residency Program, Pediatrics, 2004
    New York University
  • Internship Program, Pediatrics, 2002
    New York Hospital
  • MD, 2001
    University of Illinois at Chicago College of Medicine
  • BA, 1996
    Northwestern University
Patient Stories

Patient Stories: AeRang Kim

Patient story

Ethan's Story

"Hearing the words 'Your child has cancer' are some of the most difficult words to hear, but I want to tell you that you will get through this."

Children's National Health System

Isabel's Story

As a pediatric nurse at Children's National, I never imagined that my child would be sick.

Patient story

Staci's Story

"As a parent/caretaker, you want to fight with every ounce of fight that you have. It's normal and necessary to help you feel like you are fighting right along with your precious baby."



Targeting Tumors More Precisely, With Fewer Lasting Side Effects for Kids

Pediatric patients with cancer are often treated with a cocktail of therapies to attack the disease through a variety of mechanisms. While this approach has been instrumental in saving children’s lives, the life-saving therapies can be accompanied by acute side effects, and the treatments may have lingering impacts as cancer survivors enter adulthood.

Research & Publications

Research & Publications

Characteristics and outcome of pediatric patients enrolled on phase I oncology trials

(2008) The Oncologist

Characteristics of children enrolled on treatment trials for NF1 related plexiform neurofibromas

(2009) Neurology

Sorafenib and Sunitinib

(2009) The Oncologist

The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors

(2008) Pediatric Blood Cancer

View publications on PubMed

Invest in future cures for some of life's most devastating diseases

See other ways to give

Share your birthday with a child. Celebrate your life, and give a chance to someone who desperately wants to have as many as you.

Share your birthday with a child. Celebrate your life, and give a chance to someone who desperately wants to have as many as you.Make it happen

Christopher's Story


Christopher Melkonian was six years old when he came down with a low-grade fever and diffuse bone pain. Unsure of what was happening, his parents Darlene and David took him to Children’s National Health System and soon found out that Christopher had acute lymphoblastic leukemia (ALL), a type of blood and bone marrow cancer that affects white blood cells.

Read More of Christopher's Story